![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
We kindly request your action: To continue receiving your Amedeo newsletters, please confirm your subscription by October 1, 2023. Please check your weekly Amedeo newsletter. |
Breast Cancer |
Free Subscription
3 AJR Am J Roentgenol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Breast Cancer is free of charge.
Editorial Comment: Closing the Gap-Emerging Role of Estrogen Receptor-Targeted
PET in Invasive Lobular Carcinoma.
AJR Am J Roentgenol. 2023;221:239.
PubMed
Axillary Lymphadenopathy After a COVID-19 Vaccine Booster Dose: Time to
Resolution on Ultrasound Follow-Up and Associated Factors.
AJR Am J Roentgenol. 2023 Mar 8. doi: 10.2214/AJR.22.28970.
PubMed
Abstract available
Beyond the AJR: (99m)Tc-MDP Bone Scintigraphy-Has It Met Its Match?
AJR Am J Roentgenol. 2023 Jan 11. doi: 10.2214/AJR.23.28978.
PubMed
The role of trastuzumab deruxtecan (T-DXd) in HER2-low metastatic breast cancer
treatment.
Ann Oncol. 2023 Jul 25:S0923-7534(23)00768-8. doi: 10.1016/j.annonc.2023.
PubMed
Trastuzumab deruxtecan (T-DXd) in HER2-low metastatic breast cancer treatment.
Ann Oncol. 2023 Jul 25:S0923-7534(23)00767-6. doi: 10.1016/j.annonc.2023.
PubMed
Low Rates of Local-Regional Recurrence Among Inflammatory Breast Cancer Patients
After Contemporary Trimodal Therapy.
Ann Surg Oncol. 2023 Jul 21. doi: 10.1245/s10434-023-13906.
PubMed
Abstract available
Assessing Mode of Recurrence in Breast Cancer to Identify an Optimised Follow-Up
Pathway: 10-Year Institutional Review.
Ann Surg Oncol. 2023 Jul 21. doi: 10.1245/s10434-023-13885.
PubMed
Abstract available
ASO Visual Abstract: Risk-Adapted Intraoperative Radiation Therapy
(IORT) for Breast Cancer-Novel Analysis.
Ann Surg Oncol. 2023 Jul 22. doi: 10.1245/s10434-023-13980.
PubMed
ASO Author Reflections: Low Estrogen Receptor (ER) Expression Breast Cancer
Behaves More like ER Negative Disease and Influences Management.
Ann Surg Oncol. 2023 Jul 24. doi: 10.1245/s10434-023-13985.
PubMed
Overall Survival Following Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy
in Clinically Node Negative T1 Triple Negative Breast Cancer.
Ann Surg Oncol. 2023 Jul 25. doi: 10.1245/s10434-023-13977.
PubMed
Abstract available
ASO Author Reflections: Enhancing Preoperative Decision-Making by Using the BCSRc
to Predict Breast Cancer Surgery Complications.
Ann Surg Oncol. 2023 Jul 25. doi: 10.1245/s10434-023-14025.
PubMed
ASO Visual Abstract: Novel Dual Tracer Indocyanine Green and Radioisotope Versus
Gold Standard Sentinel Lymph Node Biopsy in Breast Cancer-The GREENORBLUE Trial.
Ann Surg Oncol. 2023 Jul 27. doi: 10.1245/s10434-023-13997.
PubMed
Implementation of a Novel Patient Decision Aid for Women with Elevated Breast
Cancer Risk Who Are Considering MRI Screening: A Pilot Study.
Ann Surg Oncol. 2023 Jul 28. doi: 10.1245/s10434-023-13901.
PubMed
Abstract available
Correlation of Beta2-Glycoprotein I With Tumor Prognosis in Breast Cancer
Patients.
Anticancer Res. 2023;43:3455-3462.
PubMed
Abstract available
Recent Postoperative Radiotherapy for Left-sided Breast Cancer Does Not Increase
Mortality of Heart Disease in Asians or Pacific Islanders: SEER Database
Analysis.
Anticancer Res. 2023;43:3571-3577.
PubMed
Abstract available
Impact of COVID-19 control on lung, breast, and colorectal pathological cancer
diagnoses. A comparison between the Netherlands, Aotearoa New Zealand, and
Northern Ireland.
BMC Cancer. 2023;23:700.
PubMed
Abstract available
Efficacy and safety of PEG-rhG-CSF versus rhG-CSF in preventing
chemotherapy-induced-neutropenia in early-stage breast cancer patients.
BMC Cancer. 2023;23:702.
PubMed
Abstract available
Understanding the contribution of lifestyle in breast cancer risk prediction: a
systematic review of models applicable to Europe.
BMC Cancer. 2023;23:687.
PubMed
Abstract available
Patient-derived organoids for precision oncology: a platform to facilitate
clinical decision making.
BMC Cancer. 2023;23:689.
PubMed
Abstract available
Breast cancer mortality in 500 000 women with early invasive breast cancer in
England, 1993-2015: population based observational cohort study.
BMJ. 2023;382:p1744.
PubMed
Correction To: Tumour-educated platelets for breast cancer detection: biological
and technical insights.
Br J Cancer. 2023 Jul 24. doi: 10.1038/s41416-023-02371.
PubMed
Effects of exercise on cancer-related cognitive impairment in breast cancer
survivors: a scoping review.
Breast Cancer. 2023 Jul 22. doi: 10.1007/s12282-023-01484.
PubMed
Abstract available
Detection of high-risk patients resistant to CDK4/6 inhibitors with hormone
receptor-positive HER2-negative advanced and metastatic breast cancer in Japan
(KBCSG-TR-1316).
Breast Cancer. 2023 Jul 24. doi: 10.1007/s12282-023-01485.
PubMed
Abstract available
Diagnostic accuracy of pre-operative breast magnetic resonance imaging (MRI) in
predicting axillary lymph node metastasis: variations in intrinsic subtypes, and
strategy to improve negative predictive value-an analysis of 2473 invasive breast
cancer p
Breast Cancer. 2023 Jul 27. doi: 10.1007/s12282-023-01488.
PubMed
Abstract available
Factors associated with non-participation in breast cancer screening: analysis of
the 2016 and 2019 comprehensive survey of living conditions in Japan.
Breast Cancer. 2023 Jul 25. doi: 10.1007/s12282-023-01486.
PubMed
Abstract available
Enhancement of PD-L1-attenuated CAR-T cell function through breast
cancer-associated fibroblasts-derived IL-6 signaling via STAT3/AKT pathways.
Breast Cancer Res. 2023;25:86.
PubMed
Abstract available
Deep learning applications to breast cancer detection by magnetic resonance
imaging: a literature review.
Breast Cancer Res. 2023;25:87.
PubMed
Abstract available
Neutrophils in triple-negative breast cancer: an underestimated player with
increasingly recognized importance.
Breast Cancer Res. 2023;25:88.
PubMed
Abstract available
The impact of cardiovascular disease on all-cause and cancer mortality: results
from a 16-year follow-up of a German breast cancer case-control study.
Breast Cancer Res. 2023;25:89.
PubMed
Abstract available
Evaluation of SNPs associated with mammographic density in European women with
mammographic density in Asian women from South-East Asia.
Breast Cancer Res Treat. 2023;201:237-245.
PubMed
Abstract available
Quantifying radiation in the axillary bed at the site of lymphedema surgical
prevention.
Breast Cancer Res Treat. 2023;201:299-305.
PubMed
Abstract available
Subtypes of high-grade breast ductal carcinoma in situ (DCIS): incidence and
potential clinical impact.
Breast Cancer Res Treat. 2023;201:329-338.
PubMed
Abstract available
Analysis of prognosis in different subtypes of invasive lobular carcinoma using
the Japanese National Cancer Database-Breast Cancer Registry.
Breast Cancer Res Treat. 2023 Jul 21. doi: 10.1007/s10549-023-07022.
PubMed
Abstract available
Diagnostic value of contrast-enhanced ultrasound for sentinel lymph node
metastasis in breast cancer: an updated meta-analysis.
Breast Cancer Res Treat. 2023 Jul 27. doi: 10.1007/s10549-023-07063.
PubMed
Abstract available
Quantifying hormone receptor status in lobular breast cancer in an institutional
series: the relationship between estrogen and progesterone receptor status and
outcomes.
Breast Cancer Res Treat. 2023 Jul 27. doi: 10.1007/s10549-023-07059.
PubMed
Abstract available
Impact of analysis of the sentinel lymph node by one-step nucleic acid
amplification (OSNA) compared to conventional histopathology on axillary and
systemic treatment: data from the Dutch nationwide cohort of breast cancer
patients.
Breast Cancer Res Treat. 2023 Jul 27. doi: 10.1007/s10549-023-07065.
PubMed
Abstract available
Effects of letrozole on serum estradiol and estrone in postmenopausal breast
cancer patients and tolerability of treatment: a prospective trial using a highly
sensitive LC-MS/MS (liquid chromatography-tandem mass spectrometry) method for
estrogen meas
Breast Cancer Res Treat. 2023 Jul 25. doi: 10.1007/s10549-023-07054.
PubMed
Abstract available
Plasma apolipoprotein M predicts overall survival in metastatic breast cancer
patients.
Breast Cancer Res Treat. 2023 Jul 25. doi: 10.1007/s10549-023-07045.
PubMed
Abstract available
Numerical and physical modeling of breast cancer based on image fusion and
artificial intelligence.
Breast Cancer Res Treat. 2023 Jul 25. doi: 10.1007/s10549-023-07056.
PubMed
Abstract available
The impact of geriatric characteristics and comorbidities on distant metastases
and other cause mortality in older women with non-metastatic breast cancer
treated with primary endocrine therapy.
Breast Cancer Res Treat. 2023 Jul 21. doi: 10.1007/s10549-023-07029.
PubMed
Abstract available
Prediction of nipple involvement in breast cancer after neoadjuvant chemotherapy:
Should we rely on breast MRI to preserve the nipple?
Breast Cancer Res Treat. 2023 Jul 25. doi: 10.1007/s10549-023-07041.
PubMed
Abstract available
Sexual health in long-term breast cancer survivors: a comparison with female
population controls from the HUNT study.
Breast Cancer Res Treat. 2023 Jul 25. doi: 10.1007/s10549-023-07021.
PubMed
Abstract available
Phase II trial of biweekly administration with eribulin after three cycles of
induction therapy in hormone receptor-positive, HER2-negative metastatic breast
cancer (JACCRO BC-03).
Breast Cancer Res Treat. 2023 Jul 22. doi: 10.1007/s10549-023-07030.
PubMed
Abstract available
Is de-escalation of treatment by omission of radiotherapy associated with fear of
cancer recurrence in women with early breast cancer? An exploratory study.
Breast Cancer Res Treat. 2023 Jul 22. doi: 10.1007/s10549-023-07039.
PubMed
Abstract available
Effectiveness of Carbon Localization for Invasive Breast Cancer: An Institutional
Experience.
Breast J. 2023;2023:4082501.
PubMed
Abstract available
Engaging black sexual minority women in breast cancer research: Lessons in
community partnerships.
Cancer. 2023 Jul 25. doi: 10.1002/cncr.34960.
PubMed
Abstract available
Racial and Ethnic Differences in the Use of Electronic Medical Record Messaging
Among Patients With Breast Cancer: A Quality Improvement Study.
Clin Breast Cancer. 2023 Jul 4:S1526-8209(23)00172.
PubMed
Abstract available
Survival Benefit of Adjuvant Chemotherapy in Node-Positive Breast Cancer With a
21-Gene Recurrence Score of 14 to 25: A Real-World Study Based on the Inverse
Probability of Treatment Weighting Method.
Clin Breast Cancer. 2023 Jul 15:S1526-8209(23)00190.
PubMed
Abstract available
Molecular Residual Disease in Breast Cancer: Detection and Therapeutic
Interception.
Clin Cancer Res. 2023 Jul 21:CCR-23-0757. doi: 10.1158/1078-0432.CCR-23-0757.
PubMed
Abstract available
Baseline mutations and ctDNA dynamics as prognostic and predictive factors in
ER-positive/HER2-negative metastatic breast cancer patients.
Clin Cancer Res. 2023 Jul 25:CCR-23-0956. doi: 10.1158/1078-0432.CCR-23-0956.
PubMed
Abstract available
GPR81-mediated reprogramming of glucose metabolism contributes to the immune
landscape in breast cancer.
Discov Oncol. 2023;14:140.
PubMed
Abstract available
TP53 Induced Glycolysis and Apoptosis Regulator and Monocarboxylate Transporter 4
drive metabolic reprogramming with c-MYC and NFkB activation in breast cancer.
Int J Cancer. 2023 Jul 27. doi: 10.1002/ijc.34660.
PubMed
Abstract available
Targeting collagen XVIII improves the efficiency of ErbB inhibitors in breast
cancer models.
J Clin Invest. 2023 Jul 27:e159181. doi: 10.1172/JCI159181.
PubMed
Abstract available
Are we there yet? Optimal duration of endocrine therapy in women with
postmenopausal early-stage hormone receptor-positive breast cancer.
J Natl Cancer Inst. 2023 Jun 30:djad111. doi: 10.1093.
PubMed
Therapeutic resistance to anti-oestrogen therapy in breast cancer.
Nat Rev Cancer. 2023 Jul 27. doi: 10.1038/s41568-023-00604.
PubMed
Abstract available
Evolutionary histories of breast cancer and related clones.
Nature. 2023 Jul 26. doi: 10.1038/s41586-023-06333.
PubMed
Abstract available
Author Correction: Phase III study of HR-positive/HER2-negative/lymph
node-positive breast cancer non-responsive to primary chemotherapy: a randomized
trial.
NPJ Breast Cancer. 2023;9:62.
PubMed
A novel transcription factor SIPA1: identification and verification in
triple-negative breast cancer.
Oncogene. 2023 Jul 27. doi: 10.1038/s41388-023-02787.
PubMed
Abstract available
Survival outcomes of breast cancer patients with recurrence after surgery
according to period and subtype.
PLoS One. 2023;18:e0284460.
PubMed
Abstract available
Circular RNA mediated gene regulation in human breast cancer: A bioinformatics
analysis.
PLoS One. 2023;18:e0289051.
PubMed
Abstract available
Global depression in breast cancer patients: Systematic review and meta-analysis.
PLoS One. 2023;18:e0287372.
PubMed
Abstract available
Caffeic acid phenethyl ester suppresses metastasis of breast cancer cells by
inactivating FGFR1 via MD2.
PLoS One. 2023;18:e0289031.
PubMed
Abstract available
alpha7 nicotinic acetylcholine receptor interaction with G proteins in breast cancer
cell proliferation, motility, and calcium signaling.
PLoS One. 2023;18:e0289098.
PubMed
Abstract available
Women's views about current and future management of Ductal Carcinoma in Situ
(DCIS): A mixed-methods study.
PLoS One. 2023;18:e0288972.
PubMed
Abstract available
One Size Fits All?-Not Anymore: Personalizing Breast Cancer Treatment with Use of
a Semiautomated Functional Tumor Volume-based Predictive Model in the Assessment
of Neoadjuvant Therapy Response.
Radiol Imaging Cancer. 2023;5:e230089.
PubMed
Updated Recommendations by the American College of Radiology for Breast Cancer
Screening in Individuals at Higher-Than-Average Risk.
Radiol Imaging Cancer. 2023;5:e239015.
PubMed
Using Synthetic MRI and Radiomics to Predict Treatment Response in
Triple-Negative Breast Cancer.
Radiol Imaging Cancer. 2023;5:e230095.
PubMed
A Radiomics Model Based on Synthetic MRI Acquisition for Predicting Neoadjuvant
Systemic Treatment Response in Triple-Negative Breast Cancer.
Radiol Imaging Cancer. 2023;5:e230009.
PubMed
Abstract available
Effect of Longitudinal Variation in Tumor Volume Estimation for MRI-guided
Personalization of Breast Cancer Neoadjuvant Treatment.
Radiol Imaging Cancer. 2023;5:e220126.
PubMed
Abstract available
Erratum for: MRI-based Quantification of Intratumoral Heterogeneity for
Predicting Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer.
Radiology. 2023;308:e239021.
PubMed
Economic evaluation and budget-impact of accelerated partial breast irradiation
(APBI) versus standard or hypofractionated whole breast irradiation (WBI) in
postmenopausal women with early-stage breast cancer. Results from the French
SHARE randomized
Radiother Oncol. 2023 Jul 20:109818. doi: 10.1016/j.radonc.2023.109818.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by